Genetics Breakthrough Could Give Us a Way to Target and Kill Cancer

A triumph in our ongoing war against cancer.

10. 3. 16 by June Javelosa
National Cancer Institute
Image by National Cancer Institute

A New Approach

Approximately 20 percent of all cancers have a mutation that makes them incredibly resistant to chemotherapy – a gene called KRAS. KRAS-mutant cancers also have very low survival rates because they are much harder to treat. Given this, researchers have focused their efforts on ways to inhibit KRAS activity. But scientists from the University of California San Diego School of Medicine alongside Moores Cancer Center have taken a unique approach that may prove to be more effective.

“Instead of trying to deter KRAS itself, we took the approach of looking for other molecules that, when inhibited, are lethal to cells only when KRAS is also mutated,” said Tariq Rana, PhD, professor of pediatrics at UC San Diego School of Medicine and Moores Cancer Center who is the senior author of the study.

microRNAs as suppressors

The new study, published October 3 in Cancer Research, focuses on inhibiting other genes to create combinations lethal to cancer cells driven by a KRAS mutation. For the study, researchers used microRNAs – which normal cells use to control what genes are turned on or off, and are less active in cancer cells. They found that one microRNA, miR-1298, could effectively suppress KRAS-dependent cell growth in colorectal and lung cancer cells.

Basically miR-1298 was able to inhibit the growth of two specific proteins in cancer cells—FAK and LAMB3, which in turn, led to KRAS-driven cancer cells to stop growing.

Advertisement

Image Credit: UC San Diego Health

Using a mouse model, Tariq Rana, PhD, and colleagues discovered microRNA miR-1298 specifically kills cancer cells with a common mutation in the KRAS gene.

Their findings revealed microRNAs as relevant tools for possibly identifying therapeutic methods of treating cancer in the future. To date, traditional methods of killing cancer cells are toxic and harmful to healthy cells. This study points us to a specific target instead, higlighting how LAMB3 can be used as a prognostic biomarker, where efforts to eliminate KRAS-driven cancers can be centralized, thus minimizing dangerous effects to the rest of the body.


Care about supporting clean energy adoption? Find out how much money (and planet!) you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.

Share This Article

Keep up.
Subscribe to our daily newsletter to keep in touch with the subjects shaping our future.
I understand and agree that registration on or use of this site constitutes agreement to its User Agreement and Privacy Policy

Advertisement

Copyright ©, Camden Media Inc All Rights Reserved. See our User Agreement, Privacy Policy and Data Use Policy. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission of Futurism. Fonts by Typekit and Monotype.